Takeda Pharmaceutical Company Limited
TAK
|
$13.85
-0.07%
0.0%
|
|
Health Technology
(0.0% 1d) (-3.9% 1m) (-18.0% 1y) (0.0% 2d) (-0.1% 3d) (0.5% 7d) (-15.38% volume)
Earnings Calendar:
http://www.takeda.co.jp
Sec Filling | Patents | 47495 employees
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
diagnostics
add to watch list email alert is off
Price chart
% (High / Open) change chart
Press-releases
Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine
Published: 2022-06-27 (Crawled : 11:00) - biospace.com/
ARWR | $34.56 6.44% 0.0% |
|
Health Technology
|
| O: 0.23%
H: 1.01%
C: -2.68%
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: 1.09%
H: 1.36%
C: 0.93%
results
Irritable Bowel Syndrome Treatment Market to Surpass US$ 3,902.9 Million by 2030 - Coherent Market Insights
Published: 2022-06-24 (Crawled : 18:00) - prnewswire.com
ALPMY | News | $15.75 -2.42% |
|
Manufacturing
|
| O: 4.33%
H: 0.0%
C: -2.44%
ALPMF | News | $16.71 5.56% |
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -0.5%
ABBV | $154.14 1.08% -0.75% |
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
BHC | News A | $8.51 -3.62% 0.0% |
|
Health Technology
|
| O: 5.78%
H: 13.91%
C: 13.78%
IRWD | $11.72 1.65% 1.45% |
|
Health Technology
|
| O: 0.27%
H: 2.08%
C: 1.99%
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
NVS | News | $84.77 0.71% -0.68% |
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: 0.0%
treatment market
Novel T-Cell Immunotherapies Market - Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic
Published: 2022-06-23 (Crawled : 08:00) - prnewswire.com
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: 1.56%
H: 0.73%
C: 0.44%
LLY | News S | $323.0 1.69% 0.07% |
|
Health Technology
|
| O: 4.14%
H: 0.0%
C: 0.0%
report t-cell trial market
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 22, 2022
Published: 2022-06-22 (Crawled : 09:00) - biospace.com/
JNJ | News | $176.99 0.03% -0.56% |
|
Health Technology
|
| O: 1.36%
H: 0.0%
C: 0.0%
ARCT A | $15.4 2.19% 0.0% |
|
Health Technology
|
| O: -0.64%
H: 14.95%
C: 10.14%
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
nasdaq grant therapeutics employment compensation
Antihypertensive Drugs Market is Estimated to Rise at a CAGR of 3% during the Forecast Period, observes TMR Study
Published: 2022-06-15 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $108.84 4.15% |
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
SNY | News | $52.67 1.02% -0.32% |
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: -1.02%
H: 1.6%
C: 1.14%
PFE | News | $50.94 0.55% -0.59% |
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: 0.0%
market
Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published: 2022-06-14 (Crawled : 11:00) - prnewswire.com
ABBV | $154.14 1.08% -0.75% |
|
Health Technology
|
| O: -1.04%
H: 0.87%
C: -1.31%
JNJ | News | $176.99 0.03% -0.56% |
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
BMY | $78.28 -0.53% -1.0% |
|
Health Technology
|
| O: -0.4%
H: 0.33%
C: -0.91%
UCBJY | $43.05 0.78% |
|
Manufacturing
|
| O: -0.22%
H: 0.0%
C: -1.02%
PFE | News | $50.94 0.55% -0.59% |
|
Health Technology
|
| O: -2.24%
H: 0.0%
C: 0.0%
AMGN | $245.43 0.79% 0.0% |
|
Health Technology
|
| O: -0.41%
H: 0.73%
C: -0.54%
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
LLY | News S | $323.0 1.69% 0.07% |
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
research system companies market
Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial
Published: 2022-06-09 (Crawled : 09:00) - biospace.com/
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: 0.18%
H: 0.66%
C: -0.88%
vaccine trial
Global Alzheimer's Disease Treatment Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F: Focus on Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins
Published: 2022-06-02 (Crawled : 10:00) - prnewswire.com
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: -3.16%
H: 0.36%
C: -0.07%
NVS | News | $84.77 0.71% -0.68% |
|
Health Technology
|
| O: -0.73%
H: 0.12%
C: 0.1%
LLY | News S | $323.0 1.69% 0.07% |
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
NVSEF | News | $84.85 1.0% |
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: 0.0%
ABBV | $154.14 1.08% -0.75% |
|
Health Technology
|
| O: -1.0%
H: 0.0%
C: 0.0%
BMY | $78.28 -0.53% -1.0% |
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
treatment disease alzheimer's alzheimer’s
Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna
Published: 2022-05-31 (Crawled : 09:00) - biospace.com/
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: -2.24%
H: 0.35%
C: -0.14%
MRNA S | $142.81 0.44% 0.83% |
|
Health Technology
|
| O: 5.09%
H: 0.0%
C: 0.0%
covid-19 for japan vaccine authorization
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
Published: 2022-05-31 (Crawled : 09:00) - biospace.com/
TAK | $13.85 -0.07% 0.0% |
|
Health Technology
|
| O: -2.24%
H: 0.35%
C: -0.14%
MRNA S | $142.81 0.44% 0.83% |
|
Health Technology
|
| O: 5.09%
H: 0.0%
C: 0.0%
covid-19 for japan vaccine authorization
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistLast 48 Hours Insiders Buying
TMCWW P 25000 | $ 0% |
|
| 02:00
LAZY P 36333 | $11.59 -3.42% -0.17% |
|
Retail Trade
| 01:40
CPSS P 40062 | $10.32 -1.71% 0.0% |
|
Finance
| 00:40
PLCE P 1500 | $38.56 -5.63% 1.14% |
|
Retail Trade
| 23:40
RWLK X | $0.92 -4.5% 3.26% |
|
Health Technology
| 21:20
SEAC P 98262 | $0.5932 -1.5% 2.75% |
|
Electronic Technology
| 21:10
RKT P 30500 | $7.23 -2.17% -3.18% |
|
Finance
| 21:00
CTBI J 500 | $40.58 -0.15% 0.0% |
|
Finance
| 20:30
PHX P 3500 | $3.0 -7.98% 0.0% |
|
Energy Minerals
| 19:00
FBNC P 973 | $34.71 -0.66% 0.0% |
|
Finance
| 18:10
CSBB P 683 | $37.5 1.21% |
|
Finance and Insurance
| 17:30
FDBC P 1000 | $39.4 -2.38% 0.0% |
|
Finance
| 16:30